Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

BACKGROUND: This analysis aimed at evaluating the impact of a therapeutic strategy of treatment simplification of atazanavir (ATV)+ ritonavir (r) + lamivudine (3TC) in virologically suppressed patients receiving ATV+r+2 nucleoside reverse transcriptase inhibitors (NRTIs) on the budget of the Italian...

Descripción completa

Detalles Bibliográficos
Autores principales: Restelli, Umberto, Fabbiani, Massimiliano, Di Giambenedetto, Simona, Nappi, Carmela, Croce, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338853/
https://www.ncbi.nlm.nih.gov/pubmed/28280375
http://dx.doi.org/10.2147/CEOR.S127097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338853/
https://www.ncbi.nlm.nih.gov/pubmed/28280375
http://dx.doi.org/10.2147/CEOR.S127097

Ejemplares similares